Phase i fast track topic 461 conformable scintillator array for in vivo dosimetry during RT
Active Definitive Contract Awarded Last action
- Contract number
- 75N91024C00083
- Awardee
-
Doseoptics LLC UEI QERKPUEMGKH3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,372,276
Award facts
- Contract value 100% obligated
- $2,372,276.00 Current and potential, with all options
- Completion date 71% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, NH 03766, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,977,698 | |
| Original award | $394,578 |
About this award
Doseoptics LLC, a for-profit limited liability company in Lebanon, New Hampshire, was awarded a $2,372,276 firm fixed price contract by the National Cancer Institute (NCI) for a Phase I Fast Track Small Business Innovation Research (SBIR) project. The contract, which is set aside for small businesses, aims to develop a "Conformable Scintillator Array for In Vivo Dosimetry During Radiation Therapy (RT)." The project seeks to improve radiation therapy precision by creating advanced monitoring technologies that can reduce normal tissue toxicity during cancer treatment. Doseoptics has also received multiple project grants from the NCI, focused on developing innovative medical imaging technologies for surgical guidance and radiation therapy monitoring, showcasing the company's expertise in this field.
Quick answers
Who was awarded contract 75N91024C00083?
75N91024C00083 was awarded to Doseoptics LLC by National Cancer Institute (National Institutes of Health) on September 16, 2024.
How much is contract 75N91024C00083 worth?
The government has obligated $2,372,276 on 75N91024C00083.
Was contract 75N91024C00083 competed?
The extent of competition for 75N91024C00083 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award